statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Talis Biomedical just reported results for the fourth quarter of 2023.
The post TLIS Stock Earnings: Talis Biomedical Reported Results...

TLIS Stock Earnings: Talis Biomedical Reported Results for Q4 2023

Gagnants
Le titre Ainos (NASDAQ:AIMD) a grimp jeudi de 101,78% 2,26 dollars lors de la session after-market.
Le titre Immuron (NASDAQ:IMRN) a grimp de 36,26% 6,20 dollars.
L'action Talis...

12 titres de soins de sant  en mouvement lors de la session apr s-cl ture le 07/03/2024

NEW YORK, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Talis Biomedical Corporation...

TALIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Talis Biomedical Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Talis Biomedical Corporation...

Talis Biomedical Corp. develops and commercializes innovative products that are designed to enable accurate, reliable, low cost and rapid molecular testing for infectious diseases. The company was founded on June 26, 2013 and is headquartered in Chicago, IL.

Talis Biomedical Corp

Volume	4,707.00
52-Wk High	$9.32
52-Wk Low	$4.35

Period	Estimated	Reported	Surprise	Result
Q4'23	-$6.68	--	--	N/A
Q3'23	-$7.37	-$8.62	-16.89%	MISSED
Q2'23	-$8.21	-$8.27	-0.76%	MISSED
Q1'23	-$10.37	-$9.90	4.56%	BEAT
Q4'22	-$10.26	--	--	N/A

TLIS Talis Biomedical Corp

About

Feed

News

Sentiment

Earnings

Fundamentals